These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 18184121)

  • 1. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.
    Serfaty L; Poujol-Robert A; Carbonell N; Chazouillères O; Poupon RE; Poupon R
    Am J Gastroenterol; 2002 Jul; 97(7):1807-12. PubMed ID: 12135040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
    J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
    Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
    J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
    Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
    Hu KQ; Lee SM; Hu SX; Xia VW; Hillebrand DJ; Kyulo NL
    Am J Gastroenterol; 2005 Sep; 100(9):2010-8. PubMed ID: 16128946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.
    Hourigan LF; Macdonald GA; Purdie D; Whitehall VH; Shorthouse C; Clouston A; Powell EE
    Hepatology; 1999 Apr; 29(4):1215-9. PubMed ID: 10094967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
    Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
    Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
    Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
    Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
    Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.